查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1943298

生物医用纺织品市场－全球产业规模、份额、趋势、机会及预测（按纤维类型、织物类型、应用、地区和竞争格局划分，2021-2031年）

Biomedical Textiles Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Fibre Type, By Fabric Type, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球生物医学纺织品市场预计将从 2025 年的 158.3 亿美元成长到 2031 年的 229.8 亿美元，复合年增长率为 6.41%。

这些特殊材料，包括工程纤维结构，对于各种生物和医学应用至关重要，其应用范围涵盖血管移植物和缝线等植入式解决方案，以及防护衣和手术敷料等非植入式产品。市场的主要驱动因素是医疗保健需求的结构性变化，特别是人口快速老化和慢性病发病率上升，这些因素共同导致手术干预次数增加，对长期伤口管理的需求也随之增长，从而对感染控制和卓越的生物相容性产生了持续的需求。

市场概览
预测期 2027-2031
市场规模：2025年 158.3亿美元
市场规模：2031年 229.8亿美元
复合年增长率：2026-2031年 6.41%
成长最快的细分市场 不可生物降解纤维
最大的市场 亚太地区

然而，由于医疗设备法规环境日益严格，市场面临巨大的挑战。製造商必须应对复杂的合规要求，例如欧洲医疗设备法规 (MDR) 和美国食品药物管理局 (FDA) 的标准，这些要求需要进行大量的临床试验，延长产品核可时间，从而增加研发成本和准入门槛。儘管面临这些商业挑战，该行业仍然是扩张的重点。据先进纺织品协会 (Advanced Textiles Association) 称，到 2024 年，24% 的受访业内人士认为医疗市场是一个关键的成长领域，这凸显了该市场在监管限制下的巨大潜力。

市场驱动因素

文明病疾病和慢性病的日益增多，从根本上改变了生物医用纺织品的需求，尤其是在长期照护和伤口管理领域。肥胖、静脉功能不全和糖尿病等疾病需要持续使用特殊纺织材料，例如压力衣和抗菌敷料，以治疗复杂的溃疡并减少继发性感染。这些不断变化的患者需求正在推动专注于先进治疗解决方案的公司实现收入成长。例如，康维特集团（Convatec Group Plc）于2024年11月发布的《截至2024年10月31日的10个月财务趋势》报告显示，集团有机销售额实现了7.7%的稳健增长。史密斯医疗（Smith+Nephew）于2024年10月发布的《2024年第三季财务业绩》也指出，其先进伤口管理部门的收入按报告数据计算增长了6.5%，反映了全球对先进创伤护理产品日益增长的需求。

同时，全球微创手术和治疗数量的不断增长是生物医用纺织品行业的关键驱动力。新兴市场医疗基础设施的完善以及全球人口老化导致医疗干预频率的增加，正推动植入式纺织产品（如血管移植物和疝气修补网片）和非植入式一次性产品（如手术罩衣和手术铺巾）的使用量相应增长。领先医疗科技公司的财务表现也印证了这一上升趋势。根据Medtronic于2024年5月发布的2024财年收益报告，其医疗外科产品组合的全球销售额成长了5.4%，这主要得益于外科解决方案领域的强劲成长。这凸显了生物相容性织物在繁忙的医院环境中维持感染控制和支持手术流程的重要作用。

市场挑战

医疗设备严格的监管架构对全球生物医用纺织品市场的扩张构成重大障碍。製造商被迫应对复杂的合规要求，包括美国食品药物管理局 (FDA) 的标准和欧盟医疗设备法规 (MDR)，这显着延长了产品核可时间并增加了研发成本。这些法规要求提供大量的临床数据和持续的上市后监测，迫使企业将大量资金和人力资源从研发转移到合规方面。这减缓了创新步伐，并延缓了植入式医疗器材和先进创伤护理所需的先进纺织医疗解决方案的普及应用。

这种营运压力直接影响企业的全球竞争力和市场扩大策略。企业越来越不愿意在合规要求繁琐的地区推出新产品，而是倾向于选择法规环境可预测的市场，或选择停止生产那些不再获利的传统纺织品。根据欧洲医疗技术展（MedTech Europe）预测，到2024年，这些复杂因素导致主要医疗设备製造商选择欧盟作为其首发产品的首选地区的比例下降了33%。这表明，合规壁垒会增加财务风险，并阻碍新型生物医学纺织技术在关键地区的商业化。

市场趋势

智慧纺织品嵌入生物感测器的兴起正在革新市场，使其价值从被动材料转变为主动数据生成诊断设备。与传统服装或绷带不同，这些电子纺织品利用奈米技术实现远端患者监护，无需侵入性设备即可即时追踪心臟活动和血压等生命征象。这项技术的融合透过实现个人化护理路径和早期疗育，支持更广泛的数位健康生态系统。作为这一进展的标誌，Nanowear 于 2024 年 1 月发布新闻稿，题为“人工智能驱动的连续血压监测和高血压诊断管理系统获得 FDA 510(k) 许可”，宣布其基于纺织品的可穿戴平台已获得 FDA 510(k)核准，这标誌着医用级纺织感测器商业化进程中的重要一步。

同时，该产业正经历着向环境永续生产技术的结构性转变，以减少合成纤维和一次性医疗耗材对环境的影响。为了在遵守严格的生物相容性标准的同时减少碳排放，製造商正越来越多地用可生物降解、生物基或回收材料取代石油化学衍生的聚合物。这一趋势既是竞争优势，也是监管要求，推动整个供应链的营运调整。根据Ahlstrom于2024年3月发布的《2023年永续发展报告》，该公司计划将其每吨产品的碳排放减少7%，这表明特种材料领域的主要企业正在为绿色製造做出切实努力。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球生物医用纺织品市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 依纤维类型（不可生物降解纤维、可生物降解纤维）
    • 依布料类型（不织布、织布、其他）
    • 依应用方式（非植入式、外科缝合线、其他）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美生物医用纺织品市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国家分析
    • 我们
    • 加拿大
    • 墨西哥

第七章 欧洲生物医用纺织品市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国家分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太生物医用纺织品市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲生物医用纺织品市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东和非洲：国家分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美洲生物医用纺织品市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国家分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 司机
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 最新进展

第十三章 全球生物医用纺织品市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的可能性
  • 供应商电力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Swicofil AG
  • DSM BV
  • Cortland Biomedical
  • Poly-Med Incorporated
  • Bally Ribbon Mills, Inc.
  • Atex Technologies Inc.
  • Medline Industries Inc.
  • B. Braun Melsungen AG
  • Integra Lifesciences Corporation
  • Elkem ASA

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 2667

The Global Biomedical Textiles Market is projected to expand from USD 15.83 Billion in 2025 to USD 22.98 Billion by 2031, registering a CAGR of 6.41%. These specialized materials, which encompass engineered fibrous structures, are essential for various biological and medical uses, ranging from implantable solutions such as vascular grafts and sutures to non-implantable items like protective apparel and surgical dressings. The market is primarily propelled by structural shifts in healthcare demand, specifically the rapidly aging global population and the increasing incidence of chronic diseases, which collectively drive the volume of surgical interventions and the necessity for long-term wound management, creating a persistent need for infection control and superior biocompatibility.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 15.83 Billion
Market Size 2031USD 22.98 Billion
CAGR 2026-20316.41%
Fastest Growing SegmentNon-Biodegradable Fibre
Largest MarketAsia Pacific

However, the market faces significant headwinds due to an increasingly rigorous regulatory environment for medical devices. Manufacturers must contend with complex compliance requirements, including the European Medical Device Regulation (MDR) and FDA standards, which demand extensive clinical trials and extend the time required for product approval, thereby elevating development costs and entry barriers. Despite these operational difficulties, the sector remains a focal point for expansion; according to the Advanced Textiles Association, in 2024, 24% of surveyed industry professionals pinpointed the medical market as a primary growth sector, underscoring its potential even amidst these regulatory constraints.

Market Driver

The increasing prevalence of lifestyle-related disorders and chronic diseases is fundamentally altering the demand landscape for biomedical textiles, especially within long-term care and wound management sectors. Conditions such as obesity, venous insufficiency, and diabetes require the consistent application of specialized fibrous materials, such as compression garments and antimicrobial dressings, to treat complex ulcers and mitigate secondary infections. This shift in patient requirements is fueling revenue growth for companies dedicated to advanced therapeutic solutions; for instance, according to Convatec Group Plc, November 2024, in the 'Trading update for the ten months ended 31 October 2024', the firm reported a strong Group organic sales growth of 7.7%, while Smith+Nephew, October 2024, in the 'Third Quarter 2024 Trading Report', noted that revenue for their Advanced Wound Management segment rose by 6.5% on a reported basis, reflecting the heightened global need for sophisticated wound care products.

Simultaneously, the rising global volume of minimally invasive and surgical procedures serves as a vital catalyst for the biomedical textiles industry. As healthcare infrastructure develops in emerging markets and the aging global population necessitates more frequent medical interventions, there is a corresponding increase in the utilization of both implantable textiles, like vascular grafts and hernia meshes, and non-implantable disposables such as surgical gowns and drapes. This upward trend is substantiated by the financial results of leading medical technology companies; according to Medtronic, May 2024, in the 'Fiscal Year 2024 Financial Results', global revenue for the Medical Surgical Portfolio grew by 5.4% due to broad strength in surgical solutions, highlighting the critical function of biocompatible fabrics in maintaining infection control and supporting surgical workflows in busy hospital environments.

Market Challenge

The stringent regulatory framework governing medical devices presents a formidable obstacle to the expansion of the Global Biomedical Textiles Market. Manufacturers are compelled to maneuver through intricate compliance systems, including the FDA standards and the European Medical Device Regulation (MDR), which significantly prolong product approval durations and drive up development expenses. These regulations necessitate exhaustive clinical data and ongoing post-market surveillance, forcing organizations to reallocate substantial capital and human resources from research and development to regulatory affairs, which subsequently decelerates the pace of innovation and delays the introduction of advanced textile-based medical solutions needed for implantable devices and sophisticated wound care.

This operational pressure directly influences global competitiveness and market expansion strategies. Companies are becoming increasingly reluctant to launch new products in regions characterized by burdensome compliance requirements, often favoring markets with more predictable regulatory environments or choosing to discontinue legacy textile products that are no longer profitable to maintain. According to MedTech Europe, in 2024, the proportion of major medical device manufacturers choosing the European Union as their priority geography for initial product launches declined by 33% due to these complexities, demonstrating how compliance hurdles heighten financial risk and actively deter the commercialization of new biomedical textile technologies in critical regions.

Market Trends

The rise of smart textiles equipped with embedded biosensors is revolutionizing the market by transitioning value from passive materials to active, data-generating diagnostic instruments. Unlike conventional garments or dressings, these e-textiles utilize nanotechnology to facilitate continuous remote patient monitoring, enabling the real-time tracking of vital signs like cardiac activity and blood pressure without the need for invasive equipment. This technological convergence supports the wider digital health ecosystem by allowing for personalized care pathways and early intervention; highlighting this progress, according to Nanowear, January 2024, in the 'Nanowear Announces FDA 510(k) Clearance for AI-enabled Continuous Blood Pressure Monitoring and Hypertension Diagnostic Management' press release, the company received approval for its cloth-based wearable platform, signifying a major step in commercializing medical-grade textile sensors.

Concurrently, the industry is experiencing a structural shift toward eco-friendly and sustainable production techniques to reduce the environmental footprint of synthetic fibers and single-use medical disposables. Manufacturers are increasingly replacing petrochemical-based polymers with biodegradable, bio-based, or recycled feedstocks to decrease their carbon emissions while adhering to rigorous biocompatibility standards. This move represents a competitive differentiator as well as a regulatory necessity, prompting operational adjustments throughout the supply chain; according to Ahlstrom, March 2024, in the 'Sustainability Report 2023', the firm realized a 7% decrease in carbon dioxide emissions per ton of production, demonstrating the concrete steps major industry players are taking toward greener manufacturing within the specialty materials sector.

Key Market Players

  • Swicofil AG
  • DSM BV
  • Cortland Biomedical
  • Poly-Med Incorporated
  • Bally Ribbon Mills, Inc.
  • Atex Technologies Inc.
  • Medline Industries Inc.
  • B. Braun Melsungen AG
  • Integra Lifesciences Corporation
  • Elkem ASA

Report Scope

In this report, the Global Biomedical Textiles Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biomedical Textiles Market, By Fibre Type

  • Non-Biodegradable Fibre
  • Biodegradable Fibre

Biomedical Textiles Market, By Fabric Type

  • Non-Woven Fabric
  • Woven Fabric
  • Others

Biomedical Textiles Market, By Application

  • Non-Implantable
  • Surgical Suture
  • Others

Biomedical Textiles Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Biomedical Textiles Market.

Available Customizations:

Global Biomedical Textiles Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Biomedical Textiles Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Fibre Type (Non-Biodegradable Fibre, Biodegradable Fibre)
    • 5.2.2. By Fabric Type (Non-Woven Fabric, Woven Fabric, Others)
    • 5.2.3. By Application (Non-Implantable, Surgical Suture, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Biomedical Textiles Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Fibre Type
    • 6.2.2. By Fabric Type
    • 6.2.3. By Application
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Biomedical Textiles Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Fibre Type
        • 6.3.1.2.2. By Fabric Type
        • 6.3.1.2.3. By Application
    • 6.3.2. Canada Biomedical Textiles Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Fibre Type
        • 6.3.2.2.2. By Fabric Type
        • 6.3.2.2.3. By Application
    • 6.3.3. Mexico Biomedical Textiles Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Fibre Type
        • 6.3.3.2.2. By Fabric Type
        • 6.3.3.2.3. By Application

7. Europe Biomedical Textiles Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Fibre Type
    • 7.2.2. By Fabric Type
    • 7.2.3. By Application
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Biomedical Textiles Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Fibre Type
        • 7.3.1.2.2. By Fabric Type
        • 7.3.1.2.3. By Application
    • 7.3.2. France Biomedical Textiles Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Fibre Type
        • 7.3.2.2.2. By Fabric Type
        • 7.3.2.2.3. By Application
    • 7.3.3. United Kingdom Biomedical Textiles Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Fibre Type
        • 7.3.3.2.2. By Fabric Type
        • 7.3.3.2.3. By Application
    • 7.3.4. Italy Biomedical Textiles Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Fibre Type
        • 7.3.4.2.2. By Fabric Type
        • 7.3.4.2.3. By Application
    • 7.3.5. Spain Biomedical Textiles Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Fibre Type
        • 7.3.5.2.2. By Fabric Type
        • 7.3.5.2.3. By Application

8. Asia Pacific Biomedical Textiles Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Fibre Type
    • 8.2.2. By Fabric Type
    • 8.2.3. By Application
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Biomedical Textiles Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Fibre Type
        • 8.3.1.2.2. By Fabric Type
        • 8.3.1.2.3. By Application
    • 8.3.2. India Biomedical Textiles Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Fibre Type
        • 8.3.2.2.2. By Fabric Type
        • 8.3.2.2.3. By Application
    • 8.3.3. Japan Biomedical Textiles Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Fibre Type
        • 8.3.3.2.2. By Fabric Type
        • 8.3.3.2.3. By Application
    • 8.3.4. South Korea Biomedical Textiles Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Fibre Type
        • 8.3.4.2.2. By Fabric Type
        • 8.3.4.2.3. By Application
    • 8.3.5. Australia Biomedical Textiles Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Fibre Type
        • 8.3.5.2.2. By Fabric Type
        • 8.3.5.2.3. By Application

9. Middle East & Africa Biomedical Textiles Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Fibre Type
    • 9.2.2. By Fabric Type
    • 9.2.3. By Application
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Biomedical Textiles Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Fibre Type
        • 9.3.1.2.2. By Fabric Type
        • 9.3.1.2.3. By Application
    • 9.3.2. UAE Biomedical Textiles Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Fibre Type
        • 9.3.2.2.2. By Fabric Type
        • 9.3.2.2.3. By Application
    • 9.3.3. South Africa Biomedical Textiles Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Fibre Type
        • 9.3.3.2.2. By Fabric Type
        • 9.3.3.2.3. By Application

10. South America Biomedical Textiles Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Fibre Type
    • 10.2.2. By Fabric Type
    • 10.2.3. By Application
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Biomedical Textiles Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Fibre Type
        • 10.3.1.2.2. By Fabric Type
        • 10.3.1.2.3. By Application
    • 10.3.2. Colombia Biomedical Textiles Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Fibre Type
        • 10.3.2.2.2. By Fabric Type
        • 10.3.2.2.3. By Application
    • 10.3.3. Argentina Biomedical Textiles Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Fibre Type
        • 10.3.3.2.2. By Fabric Type
        • 10.3.3.2.3. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Biomedical Textiles Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Swicofil AG
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. DSM BV
  • 15.3. Cortland Biomedical
  • 15.4. Poly-Med Incorporated
  • 15.5. Bally Ribbon Mills, Inc.
  • 15.6. Atex Technologies Inc.
  • 15.7. Medline Industries Inc.
  • 15.8. B. Braun Melsungen AG
  • 15.9. Integra Lifesciences Corporation
  • 15.10. Elkem ASA

16. Strategic Recommendations

17. About Us & Disclaimer